Page last updated: 2024-09-04

irofulven and Leukemia, Myeloid, Acute

irofulven has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cortes, J; Estey, E; Garcia-Manero, G; Giles, F; Kantarjian, H; Kornblau, S; Kwari, M; Murgo, A	1

Trials

1 trial(s) available for irofulven and Leukemia, Myeloid, Acute

Article	Year
Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia. Investigational new drugs, 2001, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Camptothecin; Drug Administration Schedule; Hematologic Tests; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sesquiterpenes; Survival Rate	2001

Article

Year

Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia.

Investigational new drugs, 2001, Volume: 19, Issue:1

Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Camptothecin; Drug Administration Schedule; Hematologic Tests; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sesquiterpenes; Survival Rate

2001